from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0280/PPE3

LFCtreatmentdescriptionclass of inhibitor

0.210

Amikacinug/mL Amikacintranslation

0.511

Cap5-10ug/mL Capreomycintranslation

-0.357

Rox10-50 ug/mL Roxithromycintranslation

1.158

SM2-5 ug/mL Streptomycintranslation

0.223

Tet5-10 ug/mL Tetracyclinetranslation

0.223

Rif0.2-5ug/mL Rifampicintranscription

0.051

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.235

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.178

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.090

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.397

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.060

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.087

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.735

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.433

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.200

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.085

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.626

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.781

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.683

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.134

KCN5-20 ug/mL Potassium cyaniderespiration

-0.141

NaN30.2-2 mM Sodium aziderespiration

-0.288

Nigericin50 uM Nigericinrespiration

0.175

TRC10-150 ug/mL Triclosanrespiration

-0.362

TRZ10-25 ug/mL Thioridazinerespiration

2.923

Valinomycin0.5-10 uM Valinomycinrespiration

-2.118

ZnSO42 mM ZnSO4respiration

-0.716

menadione6-10 ug/mL Menadionerespiration

-0.337

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.696

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.341

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.719

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.959

NRP_1Non-replicating persistence stage 1dosRassociated

-0.146

Amp0.2mg/mL AmpicillincellWall

-0.031

Cephalexin20-100 ug/mL CephalexincellWall

0.975

Cerulenin0.32-5 ug/mL CerulenincellWall

0.117

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.794

EMB10-20 ug/mL EthambutolcellWall

0.146

Eta12-40 ug/mL EthionamidecellWall

-0.065

INH0.2-0.4 ug/mL IsoniazidcellWall

0.248

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.243

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.697

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.053

BZA0.12 mg/mL BenzamidearomaticAmides

0.322

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.245

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.265

H2O24 mM hydrogen peroxideDNAdamaging

0.276

Levo10 ug/mL LevofloxacinDNAdamaging

0.177

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.022

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.349

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.170

UVUV-irradiationDNAdamaging

-0.695

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.212

Antimycin12.5-50 ug/mL Antimycin A?

-0.037

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.005

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.234

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.712

PA8240.2-2 ug/mL PA-824?

-3.112

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-1.377

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.111

Verapamil50 uM Verapamil?

0.901

mercaptoethanol2 mM 2-Mercaptoethanol?

0.248

methoxatin10-20 ug/mL Methoxatin?